[144] Xometry, Inc. SEC Filing

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) Rule 144 notice reports a proposed sale of 3,541 Class A common shares through UBS Financial Services on NASDAQ with an aggregate market value of $169,259. The filer states these shares were acquired by exercising stock options in May and June 2021 for a total of 3,541 shares paid in cash. The filing also discloses prior sales by the same person during the past three months totaling 19,426 shares for gross proceeds of $754,829.40 across four transactions dated June–August 2025. The notice affirms the seller does not possess undisclosed material adverse information.

Positive

• Regulatory compliance: The filer submitted a Rule 144 notice detailing the proposed sale and past transactions, meeting disclosure requirements.
• Clear acquisition history: The filing specifies the shares were acquired by exercise of stock options in May and June 2021 and paid in cash.

Negative

• Insider selling volume: The filer sold 19,426 shares in the past three months, totaling $754,829.40 in gross proceeds.
• Ongoing dispositions: The proposed sale of 3,541 shares valued at $169,259 continues recent insider sell activity.

Insights

Securities Analyst

TL;DR: Insider proposes to sell 3,541 shares; recent dispositions total 19,426 shares for ~$755k, a material run of insider selling.

The Rule 144 filing documents a routine, compliant notice for sale of restricted or control securities. Key metrics are explicit: the notice covers a proposed 3,541-share sale valued at $169,259 and prior sales of 19,426 shares generating $754,829.40 in the past three months. For investors, concentrated insider selling of this magnitude over a short window can signal liquidity needs or portfolio rebalancing rather than company fundamentals; the filing contains no new company operational data.

Corporate Governance Expert

TL;DR: Filing shows transparent compliance with Rule 144 but highlights notable insider share dispositions recently.

The submission fulfills disclosure obligations by listing acquisition method (option exercises in 2021), exact share counts, broker, and historical sales. The seller affirms absence of undisclosed material information and indicates cash payment at acquisition. This is a governance-positive action in terms of regulatory transparency, but the recent cumulative sales of 19,426 shares warrant attention from oversight committees regarding executive/shareholder communications and trading plans.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services, Inc. 11 Madison Avenue 4th Floor New York NY 10010	3541	169259.00	49339037	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	06/01/2021	Exercise of stock options	Issuer			1875	06/01/2021	Cash
Class A Common	05/16/2021	Exercise of stock options	Issuer			1666	05/16/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Peter Goguen 6116 Executive Boulevard, Suite 800 North Bethesda MD 20852	Class A Common	06/09/2025	10500	392595.00
Peter Goguen 6116 Executive Boulevard, Suite 800 North Bethesda MD 20852	Class A Common	06/17/2025	986	30124.96
Peter Goguen 6116 Executive Boulevard, Suite 800 North Bethesda MD 20852	Class A Common	07/02/2025	940	30444.44
Peter Goguen 6116 Executive Boulevard, Suite 800 North Bethesda MD 20852	Class A Common	08/07/2025	7000	301665.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for XMTR disclose about the proposed sale?

The filing discloses a proposed sale of 3,541 Class A common shares via UBS on NASDAQ with an aggregate market value of $169,259.

How were the shares acquired that are being sold under Rule 144?

The shares were acquired by exercise of stock options on 05/16/2021 (1,666 shares) and 06/01/2021 (1,875 shares), paid in cash.

How many shares did the filer sell in the past three months and for how much?

The filer sold 19,426 shares in four transactions during the past three months for gross proceeds of $754,829.40.

Through which broker will the proposed XMTR sale be executed?

The proposed sale is to be executed through UBS Financial Services, Inc. (11 Madison Avenue, New York) on the NASDAQ.

Does the filer claim any undisclosed material information about the issuer?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.